XML 94 R71.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details) - USD ($)
12 Months Ended
Mar. 29, 2023
Mar. 08, 2023
Jul. 12, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Subsequent Event [Line Items]            
Warrants, exercise price per share       $ 6.49 $ 9.09 $ 1.09
Proceeds from offering   $ 2,900,000        
Related Party, Minimum Performance Based Annual Bonus $ 250,000          
Number of shares available for issuance 500,000          
Restricted Stock [Member]            
Subsequent Event [Line Items]            
Shares granted     1,000,000 1,000,000    
Restrictions Removed on New Drug Application Date [Member]            
Subsequent Event [Line Items]            
Shares granted 250,000          
Restrictions Removed on New Drug Approval Date [Member]            
Subsequent Event [Line Items]            
Shares granted 250,000          
2021 Omnibus Incentive Plan            
Subsequent Event [Line Items]            
Number of shares available for issuance       299,784    
Dr. Jonathan Javitt [Member]            
Subsequent Event [Line Items]            
Payment Rate to Related Party Per Year $ 575,000          
Payment Rate to Related Party Per Month $ 47,916.67          
Common Stock            
Subsequent Event [Line Items]            
Common stock issued (in shares)         915,454  
Subsequent Event [Member]            
Subsequent Event [Line Items]            
Stock transfer lock in period   6 months        
Warrants, exercise price per share   $ 0.75        
Warrants exercisable beginning term   6 months        
Warrants expiration term   5 years        
Subsequent Event [Member] | Investor Warrants [Member]            
Subsequent Event [Line Items]            
Common stock issued (in shares)   3,866,666        
Subsequent Event [Member] | Common Stock            
Subsequent Event [Line Items]            
Warrants exercised   3,866,666        
Issue price (in dollars per share)   $ 0.75